Mary Anne Morgan, M.D.

Dr. Morgan practices across the spectrum of pulmonary and critical care at the University of Rochester Medical Center. An intensivist, she enjoys working with patients and their loved ones to navigate the arduous path of critical illness, with a particular interest in provider-patient communication, acute respiratory illness, and collaborative medicine. A lung specialist, she treasures the longitudinal relationships afforded in her outpatient general pulmonary practice, as well as in her specialized role as director of the Lymphangioleiomyomatosis Clinic. As an educator, she feels honored to have the opportunity to teach and learn from her patients and colleagues and enjoys sparking the curiosity of residents and fellows in her role as Program Director of the Pulmonary & Critical Care Fellowship at URMC.

Professional Background

Dr. Morgan was born and raised in Rochester, New York but left for the west coast to study American history -- and in particular the history of social change -- at Stanford University. She attended medical school at the University of California San Francisco. Tired of traffic, living in a shoebox, and being far from family, she returned to Rochester for residency training because of URMC’s focus on the biopsychosocial model of patient care. as well as by its legacy of excellence in medical education. Inspired by the clinical and academic excellence of the PCCM faculty and the warm and collegial atmosphere, she opted to stay at URMC to pursue fellowship training in Pulmonary & Critical Care. During fellowship, she was recognized for excellence in resident teaching and was named as a recipient of the T32 NIH training grant for her work in elucidating mechanisms of sepsis under the auspices of her mentor, Dr. Tony Pietropaoli. She joined the faculty upon completion of fellowship training.

Professional interests include medical education and in particular diagnostic pitfalls; the role of physician in social change and advocacy; and the care of patients with both critical illness as well as several unusual lung diseases, including lymphangioleiomyomatosis.